Dinsmore Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Dinsmore Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-10,000	Closed	-$520K	–	145
2014 Q1	$520K	Hold	10,000	–	–	0.21%	129
2013 Q4	$532K	Hold	10,000	–	–	0.22%	128
2013 Q3	$463K	Sell	10,000 -10,000	-50%	-$439K	0.19%	121
2013 Q2	$894K	Buy	+20,000	New	+$868K	0.39%	107

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dinsmore Capital Management's BMY Position: Q2 2014 in Review

Dinsmore Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2014, closing a stake of 10,000 shares — an estimated $520K sold.

Dinsmore Capital Management first reported a position in BMY in Q2 2013 and held it in 4 quarters. The position peaked at $894K in Q2 2013. 1,302 funds tracked by Wall St. Rank hold BMY as of Q2 2014.

Dinsmore Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2014 after selling out during the quarter.
Dinsmore Capital Management sold 10,000 Bristol-Myers Squibb shares in Q2 2014, an estimated $520K.
Dinsmore Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 4 quarters.
Dinsmore Capital Management's Bristol-Myers Squibb position peaked at $894K in Q2 2013.
1,302 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2014.

Based on Dinsmore Capital Management's 13F filing for Q2 2014, filed 15 Aug 2014.